A study to find the best dose of fezolinetant to treat hot flashes in women going through menopause

Trial Identifier: 2693-CL-0206
Sponsor: Astellas Pharma Inc.
Start Date: November 2021
Primary Completion Date: November 2022
Study Completion Date: December 2022

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English
Japanese

Trial Locations

Country Location
Japan, Chiba Matsudo-shi, Chiba, Japan
Japan, Fukuoka Fukuoka-shi, Fukuoka, Japan
Japan, Fukuoka Kitakyusyu-shi, Fukuoka, Japan
Japan, Hokkaido Sapporo-shi, Hokkaido, Japan
Japan, Kagawa Takamatsu-shi, Kagawa, Japan
Japan, Kagoshima Kagoshima-shi, Kagoshima, Japan
Japan, Kanagawa Sagamihara-shi, Kanagawa, Japan
Japan, Kanagawa Yokohama-shi, Kanagawa, Japan
Japan, Kyoto Kyoto-shi, Kyoto, Japan
Japan, Miyagi Sendai-shi, Miyagi, Japan
Japan, Nagano Matsumoto-shi, Nagano, Japan
Japan, Okayama Kurashiki-shi, Okayama, Japan
Japan, Osaka Osaka-shi, Osaka, Japan
Japan, Osaka Takatsuki-shi, Osaka, Japan
Japan, Saitama Saitama-shi, Saitama, Japan
Japan, Shiga Kusatsu-shi, Shiga, Japan
Japan, Shiga Omihachiman-shi, Shiga, Japan
Japan, Tokyo Chiyoda-ku, Tokyo, Japan
Japan, Tokyo Hachioji-shi, Tokyo, Japan
Japan, Tokyo Minato-ku, Tokyo, Japan
Japan, Tokyo Nerima-ku, Tokyo, Japan
Japan, Tokyo Nishitokyo-shi, Tokyo, Japan
Japan, Tokyo Setagaya-ku, Tokyo, Japan
Japan, Tokyo Toshima-ku, Tokyo, Japan
Japan, Toyama Kurobe-shi, Toyama, Japan
Japan, Toyama Uozu-shi, Toyama, Japan
Japan, Yamaguchi Shunan-shi, Yamaguchi, Japan